Literature DB >> 2328746

Effect of cimetidine and ranitidine on plasma theophylline in patients with chronic obstructive airways disease treated with theophylline and corticosteroids.

W Boehning1.   

Abstract

Thirty adults with chronic obstructive airways disease, who were stabilised on theophylline and corticosteroids, took part in a single blind study of the effects of cimetidine and ranitidine on plasma theophylline concentrations. The patients were randomised to receive either 150 mg ranitidine b.d. or 400 mg cimetidine b.d. for one week and serial plasma theophylline measurements were made over a 12-hour period on two consecutive days before, during and after treatment with the H2-antagonist. There was a significant increase in plasma theophylline during treatment with cimetidine; two patients had levels greater than 20 mg.l-1. The average increase in the theophylline concentration due to cimetidine was 32%. There was no significant change in plasma theophylline during ranitidine administration. No adverse effect occurred in any patient during the study.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328746     DOI: 10.1007/bf00314801

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Ranitidine and theophylline.

Authors:  M E Gardner; G W Sikorski
Journal:  Ann Intern Med       Date:  1985-04       Impact factor: 25.391

2.  [Drug interferences with theophylline. Absence of interaction between theophylline and ranitidine].

Authors:  F Ruff
Journal:  Nouv Presse Med       Date:  1982-11-20

3.  Ranitidine and theophylline.

Authors:  E Fernandes; F M Melewicz
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

4.  Inhibition of theophylline clearance by cimetidine but not ranitidine.

Authors:  J R Powell; J F Rogers; W A Wargin; R E Cross; F N Eshelman
Journal:  Arch Intern Med       Date:  1984-03

5.  Pharmacokinetics of theophylline and the H2-antagonist drugs cimetidine and ranitidine.

Authors:  R Dal Negro; C Pomari; O Zoccatelli; F Trevisan; C Carloni; P Turco
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1984-04

Review 6.  Pharmacokinetic drug interactions with theophylline.

Authors:  J H Jonkman; R A Upton
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

7.  Induction of theophylline toxicity and inhibition of clearance rates by ranitidine.

Authors:  A K Roy; M P Cuda; R A Levine
Journal:  Am J Med       Date:  1988-10       Impact factor: 4.965

8.  Ranitidine at very large doses does not inhibit theophylline elimination.

Authors:  H W Kelly; J R Powell; J F Donohue
Journal:  Clin Pharmacol Ther       Date:  1986-05       Impact factor: 6.875

  8 in total
  2 in total

1.  A drug use review study in patients with obstructive lung disease. Assessment of the quality of drug therapy.

Authors:  G Van den Brink; C W Bollen; O E Van de Wall; L J Hoeve; A J Porsius
Journal:  Pharm Weekbl Sci       Date:  1992-10-16

Review 2.  Side effects of ranitidine.

Authors:  T Vial; C Goubier; A Bergeret; F Cabrera; J C Evreux; J Descotes
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.